Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.6.0.2
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock 0.001 Par Value
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Balance, beginning balance at Dec. 31, 2014 $ 5,823,336 $ 15,906 $ 25,088,214 $ (18,955,024) $ (325,760)
Beginning balance, shares at Dec. 31, 2014   15,905,881      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants 8,859,767 $ 2,351 8,857,416    
Sale of common stock, shares   2,350,734      
Exercise of stock options 360,225 $ 222 360,003    
Exercise of stock options, shares   222,375      
Stock-based compensation expense 199,500   196,007   3,493
Net loss (2,800,960)     (2,727,413) (73,547)
Balance, ending balance at Dec. 31, 2015 12,441,868 $ 18,479 34,501,640 (21,682,437) (395,814)
Ending balance, shares at Dec. 31, 2015   18,478,990      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants 2,700,000 $ 675 2,699,325    
Exercise of warrants, shares   675,000      
Exercise of stock options 395,572 $ 158 395,414    
Exercise of stock options, shares   157,458      
Acquisition of non-controlling interest in Ilios, shares   670,464      
Acquisition of non-controlling interest in Ilios (31,053) $ 670 (427,537) (64,962) 460,776
Stock-based compensation expense 165,931   165,931   0
Net loss (1,161,245)     (1,096,283) (64,962)
Balance, ending balance at Dec. 31, 2016 $ 14,511,073 $ 19,982 $ 37,334,773 $ (22,843,682) $ 0
Ending balance, shares at Dec. 31, 2016   19,981,912